Metraipolis › archive › dc_fa296552fd2f

The clinical efficacy of modified xiaoyaosan in the treatment of liver Qi stagnation-type chloasma from the starting point of liver — Europe PMC PMID:41261622

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41261622
DOI: 10.1097/md.0000000000045517
License (as archived): solo-consultazione
Archived: 2026-11-09T16:27:20.720Z
SHA-256 of the archived text: 8cbb77476cd64f3a89ab474844b06fd60878958acaa72e889d982b5f12e5872e
Stable URL of this page: https://metraipolis.com/documento/dc_fa296552fd2f

How to cite

The clinical efficacy of modified xiaoyaosan in the treatment of liver Qi stagnation-type chloasma from the starting point of liver — Europe PMC PMID:41261622 — Europe PMC (en), https://europepmc.org/article/MED/41261622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa296552fd2f (Metraipolis archive dc_fa296552fd2f, sha256 8cbb77476cd64f3a89ab474844b06fd60878958acaa72e889d982b5f12e5872e)

BibTeX

@misc{dcfa296552fd2f,
  title = {The clinical efficacy of modified xiaoyaosan in the treatment of liver Qi stagnation-type chloasma from the starting point of liver — Europe PMC PMID:41261622},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41261622},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa296552fd2f; sha256 8cbb77476cd64f3a89ab474844b06fd60878958acaa72e889d982b5f12e5872e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41261622. Agents can read the archived copy with the MCP tool read_document.